Navigation Links
Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
Date:8/30/2007

License Exemplifies Broad Applicability of Anesiva's Needle-Free Technology

SOUTH SAN FRANCISCO, Calif., and OXFORD, England, Aug. 30 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) and Particle Therapeutics Limited today announced that they have entered into an agreement granting Particle Therapeutics a specific-use license to incorporate Anesiva's drug delivery technology into its needle-free, intradermal delivery system for glucagon, a hormone commonly used for the treatment of hypoglycemia associated with Type 1 and Type 2 diabetes.

"This agreement exemplifies the potential of our technology to transform the delivery of proteins, peptides and small molecules in a clinically meaningful way that is also safer, more comfortable and more convenient," said John P. McLaughlin, chief executive officer of Anesiva. "We intend to seek other opportunities for licensing this important platform technology."

"Patients experiencing a hypoglycemic condition may lose consciousness, and if not treated quickly, can suffer short and long-term cerebral damage," remarked Fred Cornhill, Director of Particle Therapeutics. "Current methods of treating diabetic hypoglycemia require the mixing of glucagon powder with a sterile saline solution, followed by needle injection. At present, an estimated 1-1.5 million kits with glucagon powder are sold annually in the U.S. and Europe. Those with Type 1 diabetes typically have at least one to eight such events per year, requiring intervention of another person or summoning of medical assistance. Type 2, insulin dependent diabetes patients have fewer incidents, but, with lower glycemic targets, the incidence of hypoglycemia, requiring third party intervention is increasing. Par
'/>"/>

SOURCE Anesiva, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. State to offer $850K in high-tech training grants
2. Grants worth $800,000 help BellBrook Labs develop products
3. Venture-backed firms could become eligible for federal SBIR grants
4. Mithridion wins grants for Alzheimers research
5. NASDAQ grants Merge more time for compliance
6. Morgridge seed grants attract over 220 proposals
7. Medical College researchers win federal grants
8. NSF grants bolster integrative graduate study at UW-Madison
9. Three state businesses receive technology grants
10. SBC Foundation awards technology grants in Wisconsin
11. Visonex plans to expand with state grants, loan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... MARINO, Calif. , May 23, 2013 /PRNewswire/ ... today a strategic alliance with DAK Renewable Research ... the corn oil yield. VG Energy is a ... (OTC Pink: VGLS). VG Energy,s exclusively ... to increase the oil yield in plants, possessing ...
(Date:5/23/2013)... , May 23, 2013 Virobay, Inc. today ... pain has reached an important milestone, as Virobay has ... - a selective cathepsin S inhibitor.   ... double-blind, randomized, placebo-controlled study designed to evaluate the safety, ... in healthy adults. "The initiation of this ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 On April ... trips to supermarkets to search for the growing antibiotic ... aisles. Results from a year long study were released ... in foods, specifically meats, over previous years. For those ... the growth of antibiotic resistant bacteria in food, may ...
(Date:5/23/2013)... 2013 Northwest Biotherapeutics (NASDAQ: NWBO ... personalized immune therapies for solid tumor cancers, announced ... year,s American Society Of Clinical Oncology (ASCO) meeting in ... role in immune therapy.  (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ... the pre-eminent conference focused on clinical treatment of cancer, ...
Breaking Biology Technology:VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3
... BNA Books , a division of BNA , announces ... of Biotechnology and the Federal Circuit , ... the entire body of Federal Circuit precedent in the rapidly ...   Biotechnology and the Federal Circuit, ...
... Medivation, Inc. (Nasdaq: MDVN ) today announced ... present at the 29th Annual J.P. Morgan Healthcare Conference on ... Westin St. Francis Hotel in San Francisco. ... clinical development programs for MDV3100 for prostate cancer and dimebon ...
... advanced technology to create high-quality dental lab products quickly ... DentalLab.com ( http://www.dentallab.com ), a new full-service dental laboratory ... around the world. DentalLab.com was founded in ... entrepreneur with a successful track record of establishing and ...
Cached Biology Technology:New Second Edition of Biotechnology and the Federal Circuit Examines the Court's Decisions on Chemical, Biotechnology, and Pharmaceutical Patent Law Cases 2New Second Edition of Biotechnology and the Federal Circuit Examines the Court's Decisions on Chemical, Biotechnology, and Pharmaceutical Patent Law Cases 3New Second Edition of Biotechnology and the Federal Circuit Examines the Court's Decisions on Chemical, Biotechnology, and Pharmaceutical Patent Law Cases 4Cutting-Edge Technologies Position DentalLab.com as Emerging Leader in Dental Lab Services Outsourcing 2
(Date:5/24/2013)... non-coding RNAs are small molecules that help control ... they have emerged as disease biomarkers. miRNA profiles ... cancers of unknown primary origin, determine prognosis, monitor ... tractable, diagnostic methods for monitoring miRNA expression in ... issue of the Journal of Clinical Investigation ...
(Date:5/24/2013)... 500 leading water scientists from around the world today ... the short span of one or two generations, the ... be living under the handicap of severe pressure on ... there is no substitute. This handicap will be self-inflicted ... bluntly pointed to chronic underlying problems led by mismanagement ...
(Date:5/23/2013)... Laboratory honored more than 165 staff for their ... PNNL,s annual Intellectual Property Commercialization Recognition & Rewards ... national laboratory named materials scientist Jun Liu Inventor ... materials that can store large amounts of energy, ... the time it takes to charge cell phones, ...
Breaking Biology News(10 mins):A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 2A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 3A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 4PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2
... are finding new ways to block the movement of cells ... spread of cancer. Led by Professor of Immunology Shaun ... of cells which are involved in helping cells migrate to ... of diseases like cancer and autoimmune diseases, such as multiple ...
... The European Molecular Biology Organization (EMBO) and the Federation ... the German Cancer Research Center in Heidelberg, Germany, as ... Award. Ingrid Grummt has made important contributions to the ... The FEBS/EMBO Women in Science Award, now in ...
... the ACSS has collected a number of stories which demonstrates ... improve everyone,s wellbeing. The impact of social science research is ... healthy diets and the wellbeing of children. As ... her research on the value of fathers and grandparents in ...
Cached Biology News:2010 FEBS/EMBO Women in Science award honors Ingrid Grummt 2
... new Hummingbird has the ability to quickly and ... makes it a perfect candidate for inclusion in ... OCX interface supplied with all the Cartesian products ... Hummingbirds ability to copy plates in seconds ...
Sigmas E-TOXATE (Limulus Amebocyte Lysate) test kits are intended for the detection and semiquantitation of endotoxins for research purposes. sensitivity 0.05-0.1 EU/mL...
... isolation chamber provides a safe, clean ... pharmaceuticals, in accord with USP-797 requirements. ... (ISO 5) cleanliness conditions in the ... rod and tilt-up front panel for ...
... Protein determined by Biuret. Physical ... (NH 4 ) 2 SO ... Note: Affinity purified • Physical ... Additives: MgCl 2 1 ...
Biology Products: